ARISTADA: payments to doctors
Payments that named ARISTADA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $101.5M
- Providers
- 38,523
- Transactions
- 1,199,514
- Average per transaction
- $85
The per-transaction average — $85 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 38,523 providers the average total is $2,636, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Alkermes, Inc. | $101,527,757 | 100.0% |